Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 06/30/2019 (updated monthly) $1,206.0 (M)
Net Assets - Advisor ClassAs of 06/30/2019 (updated monthly) $164.6 (M)
P/E Ratio (12-mo Forward)As of 06/30/2019 (updated monthly) 14.97
P/B RatioAs of 06/30/2019 (updated monthly) 5.54

Positions As of 06/30/2019

Number of Issuers 82

All Retail Fund Holdings Reports

Portfolio Details

Asset AllocationAs of 06/30/2019

[name] [value]
Equity 94.59%
Cash & Cash Equivalents 5.41%

Geographic BreakdownAs of 06/30/2019

No chart available for this data.
[name] [value]
United States 83.02%
Cash & Cash Equivalents 5.41%
United Kingdom 3.95%
Netherlands 3.06%
Denmark 2.46%
Canada 0.75%
Switzerland 0.65%
Germany 0.55%
Israel 0.14%

sector breakdownAs of 06/30/2019

[name] [value]
Biotechnology 76.28%
Pharmaceuticals 13.01%
Cash & Cash Equivalents 5.41%
Life Sciences Tools & Services 5.30%

TOP TEN HOLDINGSAs of 06/30/2019

43.35%
Other
0% 100%
[holdings-table-heading]
ALEXION PHARMACEUTICALS INC 6.50%
ILLUMINA INC 5.30%
VERTEX PHARMACEUTICALS INC 5.08%
GILEAD SCIENCES INC 4.88%
IOVANCE BIOTHERAPEUTICS INC 4.05%
GW PHARMACEUTICALS PLC 3.95%
BIOGEN INC 3.67%
ARRAY BIOPHARMA INC 3.60%
AMGEN INC 3.18%
BIOMARIN PHARMACEUTICAL INC 3.14%

You need Adobe Acrobat Reader 6.0 or higher to view and print PDF documents. Download a free version from Adobe's website.